Release Date: 30/04/18 16:30 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 585.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%